This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: USA as Represented by Secretary of the Navy. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Shahida Baqar: Innovator in Immunogenic Compositions
Introduction
Shahida Baqar is a notable inventor based in Olney, MD (US). She has made significant contributions to the field of immunology, particularly through her innovative compositions that aim to induce immune responses without adverse effects.
Latest Patents
Shahida Baqar holds 3 patents that reflect her expertise in immunogenic compositions. Her latest patents include an immunogenic composition that is composed of a capsule polysaccharide polymer from one or more strains. This composition can be used alone or conjugated to a carrier molecule, such as CRM. A key aspect of this invention is its ability to induce an immune response without causing Guillain-Barré Syndrome. Another patent relates to an immunogenic composition made from secreted polypeptides derived from non-flagellar proteins that are coordinately expressed with the flagellar regulon. This invention also includes a method for inducing an immune response to these non-flagellar protein polypeptides.
Career Highlights
Throughout her career, Shahida Baqar has worked with various organizations, including the United States Navy and the University of Guelph. Her work has been instrumental in advancing the understanding and application of immunogenic compositions.
Collaborations
Shahida has collaborated with notable colleagues such as Patricia Guerry-Kopecko and Mario Artur Monteiro, contributing to her innovative research and development efforts.
Conclusion
Shahida Baqar's contributions to immunology through her patents and collaborations highlight her role as a significant inventor in the field. Her work continues to influence the development of safe and effective immunogenic compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile